.jpg)
.png)
The theme of this issue of LipidSpin is “Unusual Causes of Dyslipidemia/Less Common Dyslipidemias.” Topics range from sitosterolemia, to lysosomal acid lipase deficiency, to myositis due to red yeast rice. Although not necessarily rare for many lipidologists, other topics include potential worsening of lipoproteins with a low-carb diet, issues regarding dyslipidemia and antipsychotic medications, and use of niacin-statin combination in lipid management.
Article By:
Secretary, National Lipid Association
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY
Diplomate, American Board of Clinical Lipidology
As clinical lipidogists, the major objective of care for most of our patients is to reduce the risk of atherosclerotic cardiovascular disease (ASCVD).
Article By:
Associate Professor of Medicine
University of Miami School of Medicine
Director, Lipid Clinic and Cardiovascular Risk Reduction Program
Miami, FL Diplomate, American Board of Clinical Lipidology
Happy New Year from the Foundation of the National Lipid Association! We are hard at work ensuring that 2016 is as much of a success as 2015.
Article By:
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
A passionate supporter of the National Lipid Association (NLA) and an advocate of clinical lipidology, Elizabeth (Beth) Jackson is a woman of many talents. Jackson works as a clinical nurse specialist and clinical lipid specialist with Edward R. Chafizadeh, MD, at CardioTexas in Austin, Texas. Some states do not work with clinical nurse specialists in the same capacity, but Jackson’s role is an advanced practice provider specializing in cardiology and lipidology.
Article By:
Clinical Nurse Specialist
CardioTexas, St. David’s Medical Center
Austin, TX
Diplomate, Accreditation Council of Clinical Lipidology
The Southwest Chapter of the National Lipid Association (SWLA) established three primary goals we planned to achieve at the NLA Scientific Sessions last June in Chicago.
Article By:
Clinical Professor, Western University/COMP
Denver, CO
Diplomate, American Board of Clinical Lipidology
Muscle symptoms in patients on statin therapy are prevalent and offer a complicated differential for providers to entertain. Symptoms range from relatively mild aches and pains to severe and debilitating weakness and pain. Statins are taken by more than 25 million patients across the globe and have been clearly associated with such complaints.
Article By:
CardioTexas
St. David’s Medical Center
Austin, TX
Diplomate, Accreditation Council of Clinical Lipidology
CardioTexas
St. David’s Medical Center
Austin, TX
Hospital Internists of Austin
St. David’s Medical Center
Austin, TX
Clinical question: In statin-treated patients who also require strong CYP3A4 inducers, does statin therapy need to be preemptively modified to account for decreased systemic exposure secondary to increased metabolism?
Article By:
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente of Colorado
Clinical Assistant Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, CO
Diplomate, Accreditation Council of Clinical Lipidology
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente of Colorado
Clinical Instructor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, CO
In keeping with the theme of this issue of the LipidSpin, this Specialty Corner is devoted to advice for the practicing clinician who has to make daily decisions on how best to protect his/her patients from cardiovascular disease.
Article By:
Glendale, AZ
Private Practice
Scottsdale, AZ
Diplomate, American Board of Clinical Lipidology
The American College of Cardiology/American Heart Association (ACC/AHA) Blood Cholesterol Guideline recommends high-intensity statin therapy for high-risk patients to reduce the risk of major adverse cardiovascular events (MACE).1 Despite treatment with high-intensity statins, patients continue to experience MACE. Additionally, some patients have a less-than-anticipated response to, or are unable to, tolerate high-intensity statins.
Article By:
University of Colorado Anschutz Medical Campus
Aurora, CO
Kaiser Permanente Colorado
Aurora, CO
This edition of the LipidSpin is devoted to guidelines vs. guidance. We all strive to practice evidence-based medicine (EBM) and our understanding of science has moved forward at a quick pace. Multiple journals come out every week with new articles that advance medicine’s knowledge base. Large, randomized controlled trials (RCTs) get headlines when a positive or negative result is found.
Article By:
Colorado Springs Health Partners
Adjunct Associate Professor of Family Medicine and Community Preceptor
University of Colorado, Department of Family Medicine
Colorado Springs, CO
Diplomate, American Board of Clinical Lipidology
University of Colorado
Aurora, CO
Diplomate, Accreditation Council of Clinical Lipidology